Overview

Brain Imaging and Treatment Studies of the Night Eating Syndrome

Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of the anti-depressant Lexapro in the treatment of the Night Eating Syndrome.
Phase:
Phase 3
Details
Lead Sponsor:
University of Pennsylvania
Collaborator:
Forest Laboratories
Treatments:
Citalopram
Dexetimide